388 related articles for article (PubMed ID: 30547358)
1. Intensity-modulated radiotherapy and hypofractionated volumetric modulated arc therapy for elderly patients with breast cancer: comparison of acute and late toxicities.
Fiorentino A; Gregucci F; Mazzola R; Figlia V; Ricchetti F; Sicignano G; Giajlevra N; Ruggieri R; Fersino S; Naccarato S; Massocco A; Corradini S; Alongi F
Radiol Med; 2019 Apr; 124(4):309-314. PubMed ID: 30547358
[TBL] [Abstract][Full Text] [Related]
2. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
3. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
[TBL] [Abstract][Full Text] [Related]
4. Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients.
Fiorentino A; Mazzola R; Giaj Levra N; Fersino S; Ricchetti F; Di Paola G; Gori S; Massocco A; Alongi F
Aging Clin Exp Res; 2018 May; 30(5):533-538. PubMed ID: 28755327
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated volumetric-modulated arc therapy for breast cancer: A propensity-score-weighted comparison of radiation-related toxicity.
Kim N; Chang JS; Shah C; Shin H; Keum KC; Suh CO; Kim YB
Int J Cancer; 2021 Jul; 149(1):149-157. PubMed ID: 33600612
[TBL] [Abstract][Full Text] [Related]
6. Assessment of acute toxicities and early local recurrences in post mastectomy breast cancer patients by accelerated hypofractionated radiotherapy; a single arm clinical trial.
Vijayaraghavan N; Vedasoundaram P; M Mathew J; Menon A; Kannan B
J BUON; 2020; 25(5):2265-2270. PubMed ID: 33277844
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
[TBL] [Abstract][Full Text] [Related]
8. VMAT partial-breast irradiation: acute toxicity of hypofractionated schedules of 30Â Gy in five daily fractions.
La Rocca E; Lozza L; D' Ippolito E; Dispinzieri M; Giandini C; Bonfantini F; Valdagni R; Folli S; Pignoli E; Di Cosimo S; De Santis MC
Clin Transl Oncol; 2020 Oct; 22(10):1802-1808. PubMed ID: 32128672
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated volumetric modulated arc therapy in ductal carcinoma in situ: toxicity and cosmetic outcome from a prospective series.
De Rose F; Fogliata A; Franceschini D; Iftode C; Torrisi R; Masci G; Sagona A; Tinterri C; Testori A; Gatzemeier W; Fernandes B; Rahal D; Cozzi L; Santoro A; Scorsetti M
Br J Radiol; 2018 May; 91(1085):20170634. PubMed ID: 29322827
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results.
De Rose F; Fogliata A; Franceschini D; Navarria P; Villa E; Iftode C; D'Agostino G; Cozzi L; Lobefalo F; Mancosu P; Tomatis S; Scorsetti M
Radiat Oncol; 2016 Sep; 11(1):120. PubMed ID: 27639373
[TBL] [Abstract][Full Text] [Related]
11. Volumetric modulated arc therapy (VMAT) to deliver nodal irradiation in breast cancer patients.
Iorio GC; Franco P; Gallio E; Martini S; Arcadipane F; Bartoncini S; Rondi N; Giglioli FR; Ala A; Airoldi M; Donadio M; De Sanctis C; Castellano I; Ricardi U
Med Oncol; 2017 Nov; 35(1):1. PubMed ID: 29209826
[TBL] [Abstract][Full Text] [Related]
12. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
Karpf D; Sakka M; Metzger M; Grabenbauer GG
Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a mixed beam therapy for postmastectomy breast cancer patients: Bolus electron conformal therapy combined with intensity modulated photon radiotherapy and volumetric modulated photon arc therapy.
Zhang R; Heins D; Sanders M; Guo B; Hogstrom K
Med Phys; 2018 Jul; 45(7):2912-2924. PubMed ID: 29749075
[TBL] [Abstract][Full Text] [Related]
14. Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy.
Haertl PM; Pohl F; Weidner K; Groeger C; Koelbl O; Dobler B
Med Dosim; 2013; 38(1):1-4. PubMed ID: 22727550
[TBL] [Abstract][Full Text] [Related]
15. Hybrid volumetric-modulated arc therapy for postoperative breast cancer including regional lymph nodes: the advantage of dosimetric data and safety of toxicities.
Doi Y; Nakao M; Miura H; Ozawa S; Kenjo M; Nagata Y
J Radiat Res; 2020 Sep; 61(5):747-754. PubMed ID: 32785596
[TBL] [Abstract][Full Text] [Related]
16. [Dosimetric comparison of the helical tomotherapy, intensity-modulated radiotherapy and volumetric-modulated arc therapy in radical radiotherapy for esophageal cancer].
Xu YJ; Li P; Hu X; Wang J; Ma HL; Chen M
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3260-3265. PubMed ID: 31694123
[No Abstract] [Full Text] [Related]
17. Volumetric-Modulated Arc Radiotherapy with Daily Image-Guidance Carries Better Toxicity Profile for Higher Risk Prostate Cancer.
Ghanem AI; Elsaid AA; Elshaikh MA; Khedr GA
Asian Pac J Cancer Prev; 2021 Jan; 22(1):61-68. PubMed ID: 33507680
[TBL] [Abstract][Full Text] [Related]
18. Left-sided breast cancer loco-regional radiotherapy with deep inspiration breath-hold: Does volumetric-modulated arc radiotherapy reduce heart dose further compared with tangential intensity-modulated radiotherapy?
Pham TT; Ward R; Latty D; Owen C; Gebski V; Chojnowski J; Kelly C; Ahern V; Tiver K; Stuart K; Wang W
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):545-53. PubMed ID: 27094588
[TBL] [Abstract][Full Text] [Related]
19. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
[TBL] [Abstract][Full Text] [Related]
20. Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results.
Macchia G; Deodato F; Cilla S; Torre G; Corrado G; Legge F; Gambacorta MA; Tagliaferri L; Mignogna S; Scambia G; Valentini V; Morganti AG; Ferrandina G
Oncol Rep; 2014 Nov; 32(5):2237-43. PubMed ID: 25175950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
